Functional network dysconnectivity as a biomarker of treatment resistance in schizophrenia

  • Carolyn B. McNabb
  • , Roger J. Tait
  • , Meghan E. McIlwain
  • , Valerie M. Anderson
  • , John Suckling
  • , Robert R. Kydd
  • , Bruce R. Russell*
  • *Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    42 Citations (SciVal)
    Original languageEnglish
    Pages (from-to)160-167
    Number of pages8
    JournalSchizophrenia Research
    Volume195
    DOIs
    Publication statusPublished (VoR) - May 2018

    Funding

    Carolyn McNabb was supported by a Vernon Tews Education Trust scholarship. Meghan McIlwain was supported by a University of Auckland Doctoral Scholarship and a New Zealand Federation of Graduate Women Fellowship. Valerie Anderson was supported by an Edith C. Coan Research Fellowship from The Auckland Medical Research Foundation. This work was supported by The University of Auckland Faculty Research and Development Fund Project number 3624739 , with support from the New Zealand Pharmacy Education and Research Fund Grant number 263 , the New Zealand Schizophrenia Research Group Donation and the Oakley Mental Health Research Foundation .

    Keywords

    • Clozapine
    • Magnetic resonance imaging
    • Network based statistics
    • Schizophrenia
    • Treatment resistance
    • Treatment response

    Fingerprint

    Dive into the research topics of 'Functional network dysconnectivity as a biomarker of treatment resistance in schizophrenia'. Together they form a unique fingerprint.

    Cite this